MedTrace Logo

To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis

NCT03301844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2019-12-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of, and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis.

Conditions

  • Bilateral Blepharitis (Disorder)

Interventions

COMBINATION_PRODUCT

Blephapad Combo

Blephapad Combo is used to cleanse, soften, sooth and decongest inflamed eyelids and cilia. The combo also presents an applicator with a heatable tablet that is applied to the eyelid in order to clean and open occluded Meibomian glands, thereby allowing the production of lipids necessary for a healthy tear film. The heatable tablet is to be used prior to cleansing with Blephapad wipes.

OTHER

Standard treatment

Standard treatment, twice daily for one month, consisting in eyelid hygiene using wet, warm gauze.

Sponsors & Collaborators

  • NTC srl

    lead INDUSTRY

Principal Investigators

  • Vincenzo Scorcia · A.O.U. Policlinico Mater Domini

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-02-09
Completion
2018-02-09

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03301844 on ClinicalTrials.gov